• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与健康相关的生活质量与慢性阻塞性肺疾病的严重程度相关。

Health-related quality of life is related to COPD disease severity.

作者信息

Ståhl Elisabeth, Lindberg Anne, Jansson Sven-Arne, Rönmark Eva, Svensson Klas, Andersson Fredrik, Löfdahl Claes-Göran, Lundbäck Bo

机构信息

Department of Respiratory Medicine and Allergology, University Hospital, SE-221 85 Lund, Sweden.

出版信息

Health Qual Life Outcomes. 2005 Sep 9;3:56. doi: 10.1186/1477-7525-3-56.

DOI:10.1186/1477-7525-3-56
PMID:16153294
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1215504/
Abstract

BACKGROUND

The aim of this study was to evaluate the association between health-related quality of life (HRQL) and disease severity using lung function measures.

METHODS

A survey was performed in subjects with COPD in Sweden. 168 subjects (70 women, mean age 64.3 years) completed the generic HRQL questionnaire, the Short Form 36 (SF-36), the disease-specific HRQL questionnaire; the St George's Respiratory Questionnaire (SGRQ), and the utility measure, the EQ-5D. The subjects were divided into four severity groups according to FEV1 per cent of predicted normal using two clinical guidelines: GOLD and BTS. Age, gender, smoking status and socio-economic group were regarded as confounders.

RESULTS

The COPD severity grades affected the SGRQ Total scores, varying from 25 to 53 (GOLD p = 0.0005) and from 25 to 45 (BTS p = 0.0023). The scores for SF-36 Physical were significantly associated with COPD severity (GOLD p = 0.0059, BTS p = 0.032). No significant association were noticed for the SF-36, Mental Component Summary scores and COPD severity. Scores for EQ-5D VAS varied from 73 to 37 (GOLD I-IV p = 0.0001) and from 73 to 50 (BTS 0-III p = 0.0007). The SGRQ Total score was significant between age groups (p = 0.0047). No significant differences in HRQL with regard to gender, smoking status or socio-economic group were noticed.

CONCLUSION

The results show that HRQL in COPD deteriorates with disease severity and with age. These data show a relationship between HRQL and disease severity obtained by lung function.

摘要

背景

本研究旨在通过肺功能指标评估健康相关生活质量(HRQL)与疾病严重程度之间的关联。

方法

在瑞典对慢性阻塞性肺疾病(COPD)患者进行了一项调查。168名受试者(70名女性,平均年龄64.3岁)完成了通用HRQL问卷、简明健康调查问卷(SF-36)、疾病特异性HRQL问卷;圣乔治呼吸问卷(SGRQ)以及效用测量工具EQ-5D。根据两种临床指南(全球慢性阻塞性肺疾病倡议(GOLD)和英国胸科学会(BTS)),按照预测正常FEV1百分比将受试者分为四个严重程度组。年龄、性别、吸烟状况和社会经济群体被视为混杂因素。

结果

COPD严重程度等级影响SGRQ总分,范围从25至53(GOLD,p = 0.0005)以及从25至45(BTS,p = 0.0023)。SF-36身体维度得分与COPD严重程度显著相关(GOLD,p = 0.0059;BTS,p = 0.032)。未发现SF-36心理维度总分得分与COPD严重程度之间存在显著关联。EQ-5D视觉模拟量表(VAS)得分范围从73至37(GOLD I-IV,p = 0.0001)以及从73至50(BTS 0-III,p = 0.0007)。SGRQ总分在年龄组之间存在显著差异(p = 0.0047)。未发现HRQL在性别、吸烟状况或社会经济群体方面存在显著差异。

结论

结果表明,COPD患者的HRQL随疾病严重程度和年龄而恶化。这些数据显示了HRQL与通过肺功能获得的疾病严重程度之间的关系。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b308/1215504/6254465c11ae/1477-7525-3-56-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b308/1215504/1033cc15b3ee/1477-7525-3-56-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b308/1215504/6254465c11ae/1477-7525-3-56-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b308/1215504/1033cc15b3ee/1477-7525-3-56-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b308/1215504/6254465c11ae/1477-7525-3-56-2.jpg

相似文献

1
Health-related quality of life is related to COPD disease severity.与健康相关的生活质量与慢性阻塞性肺疾病的严重程度相关。
Health Qual Life Outcomes. 2005 Sep 9;3:56. doi: 10.1186/1477-7525-3-56.
2
Health-related quality of life is associated with COPD severity: a comparison between the GOLD staging and the BODE index.健康相关生活质量与慢性阻塞性肺疾病严重程度相关:慢性阻塞性肺疾病全球倡议(GOLD)分期与BODE指数的比较
Chron Respir Dis. 2009;6(2):75-80. doi: 10.1177/1479972308101551.
3
BODE index and quality of life in advanced chronic obstructive pulmonary disease before and after lung transplantation.BODE 指数与肺移植前后晚期慢性阻塞性肺疾病患者的生活质量。
J Heart Lung Transplant. 2011 Dec;30(12):1334-41. doi: 10.1016/j.healun.2011.06.006. Epub 2011 Jul 22.
4
The cross-sectional and longitudinal association of the BODE index with quality of life in patients with chronic obstructive pulmonary disease.BODE 指数与慢性阻塞性肺疾病患者生活质量的横断面和纵向关联。
Chin Med J (Engl). 2009 Dec 20;122(24):2939-44.
5
Assessing health-related quality of life in COPD: comparing generic and disease-specific instruments with focus on comorbidities.评估慢性阻塞性肺疾病患者与健康相关的生活质量:比较通用型和疾病特异性工具,并重点关注合并症。
BMC Pulm Med. 2016 May 10;16(1):70. doi: 10.1186/s12890-016-0238-9.
6
Health-related quality of life, utility, and productivity outcomes instruments: ease of completion by subjects with COPD.与健康相关的生活质量、效用和生产力结果测量工具:慢性阻塞性肺疾病患者完成的难易程度。
Health Qual Life Outcomes. 2003 Jun 2;1:18. doi: 10.1186/1477-7525-1-18.
7
Health-related quality of life in outpatient women with COPD in daily practice: the MUVICE Spanish study.日常实践中门诊 COPD 女性患者的健康相关生活质量:MUVICE 西班牙研究。
Respir Med. 2009 Sep;103(9):1303-12. doi: 10.1016/j.rmed.2009.04.002. Epub 2009 Apr 29.
8
Relapse of health related quality of life and psychological health in patients with chronic obstructive pulmonary disease 6 months after rehabilitation.慢性阻塞性肺疾病患者康复6个月后健康相关生活质量和心理健康的复发情况
Scand J Caring Sci. 2012 Jun;26(2):219-27. doi: 10.1111/j.1471-6712.2011.00921.x. Epub 2011 Sep 5.
9
Does quality of life of COPD patients as measured by the generic EuroQol five-dimension questionnaire differentiate between COPD severity stages?采用通用的欧洲五维健康量表问卷测量的慢性阻塞性肺疾病(COPD)患者的生活质量能否区分COPD的严重程度阶段?
Chest. 2006 Oct;130(4):1117-28. doi: 10.1378/chest.130.4.1117.
10
Comparison of health-related quality of life measures in chronic obstructive pulmonary disease.慢性阻塞性肺疾病患者健康相关生命质量测评指标的比较。
Health Qual Life Outcomes. 2011 Apr 18;9:26. doi: 10.1186/1477-7525-9-26.

引用本文的文献

1
Glycopyrrolate/formoterol fumarate MDI in mild-to-moderate chronic obstructive pulmonary disease (PIONEER): a protocol for a randomised, double-blind, placebo-controlled trial.格隆溴铵/富马酸福莫特罗定量吸入气雾剂用于轻至中度慢性阻塞性肺疾病(先锋研究):一项随机、双盲、安慰剂对照试验方案
BMJ Open Respir Res. 2025 Jun 15;12(1):e002656. doi: 10.1136/bmjresp-2024-002656.
2
Differences in COPD management across clinician type: Maintenance treatment habits and patient characteristics among US pulmonologists, internal/family medicine physicians, nurse practitioners, and physician assistants.不同临床医生类型在慢性阻塞性肺疾病(COPD)管理方面的差异:美国肺科医生、内科/家庭医学医生、执业护士和医师助理的维持治疗习惯及患者特征
Chron Respir Dis. 2025 Jan-Dec;22:14799731251346191. doi: 10.1177/14799731251346191. Epub 2025 Jun 5.
3

本文引用的文献

1
Do GOLD stages of COPD severity really correspond to differences in health status?慢性阻塞性肺疾病(COPD)严重程度的GOLD分期真的与健康状况差异相对应吗?
Eur Respir J. 2003 Sep;22(3):444-9. doi: 10.1183/09031936.03.00101203.
2
Not 15 but 50% of smokers develop COPD?--Report from the Obstructive Lung Disease in Northern Sweden Studies.不是15%而是50%的吸烟者会患慢性阻塞性肺疾病?——来自瑞典北部阻塞性肺病研究的报告。
Respir Med. 2003 Feb;97(2):115-22. doi: 10.1053/rmed.2003.1446.
3
Costs of COPD in Sweden according to disease severity.瑞典慢性阻塞性肺疾病(COPD)的成本按疾病严重程度划分。
Determinants of poor chronic obstructive pulmonary disease control.慢性阻塞性肺疾病控制不佳的决定因素。
Libyan J Med. 2025 Dec;20(1):2507987. doi: 10.1080/19932820.2025.2507987. Epub 2025 May 19.
4
Bisoprolol for patients with chronic obstructive pulmonary disease at high risk of exacerbation: the BICS RCT.比索洛尔用于慢性阻塞性肺疾病急性加重高风险患者:BICS随机对照试验
Health Technol Assess. 2025 May;29(17):1-97. doi: 10.3310/TNDG8641.
5
Long-Term SGRQ Stability in a Cohort of Individuals with Alpha-1 Antitrypsin Deficiency-Associated Lung Disease.α1抗胰蛋白酶缺乏相关肺部疾病患者队列中圣乔治呼吸问卷(SGRQ)的长期稳定性
Int J Chron Obstruct Pulmon Dis. 2024 Apr 10;19:889-900. doi: 10.2147/COPD.S443183. eCollection 2024.
6
A Chronic Obstructive Pulmonary Disease Self-Management Intervention for Improving Patient-Reported Outcomes in Primary Care in Greece.希腊的一项慢性阻塞性肺疾病自我管理干预措施,旨在改善初级保健中的患者报告结局。
Medicina (Kaunas). 2024 Feb 23;60(3):377. doi: 10.3390/medicina60030377.
7
Comparison of Disease Severity Classifications of Chronic Obstructive Pulmonary Disease: GOLD vs. STAR in Clinical Practice.慢性阻塞性肺疾病疾病严重程度分类的比较:临床实践中全球慢性阻塞性肺疾病倡议(GOLD)与慢性阻塞性肺疾病评估测试(STAR)的对比
Diagnostics (Basel). 2024 Mar 19;14(6):646. doi: 10.3390/diagnostics14060646.
8
Clinical and economic burden of anxiety/depression among older adult COPD patients: evidence from the COPD-AD China Registry study.老年慢性阻塞性肺疾病患者焦虑/抑郁的临床和经济负担:来自慢性阻塞性肺疾病-焦虑/抑郁中国注册研究的证据
Front Psychiatry. 2024 Jan 8;14:1221767. doi: 10.3389/fpsyt.2023.1221767. eCollection 2023.
9
COPD after "Tabouna" Exposure: A Distinct Phenotype in Tunisian Women?“塔布纳”暴露后慢性阻塞性肺疾病:突尼斯女性中的一种独特表型?
J Clin Med. 2023 Nov 30;12(23):7424. doi: 10.3390/jcm12237424.
10
Health-related quality of life and its associated factors in patients with chronic obstructive pulmonary disease.慢性阻塞性肺疾病患者的健康相关生活质量及其相关因素。
PLoS One. 2023 Oct 26;18(10):e0293342. doi: 10.1371/journal.pone.0293342. eCollection 2023.
Chest. 2002 Dec;122(6):1994-2002. doi: 10.1378/chest.122.6.1994.
4
The relationship of perceived self-efficacy to quality of life in chronic obstructive pulmonary disease.慢性阻塞性肺疾病患者自我效能感与生活质量的关系。
Health Psychol. 2002 Nov;21(6):610-4. doi: 10.1037//0278-6133.21.6.610.
5
Survival in COPD patients after regular use of fluticasone propionate and salmeterol in general practice.在全科医疗中,慢性阻塞性肺疾病(COPD)患者长期使用丙酸氟替卡松和沙美特罗后的生存率。
Eur Respir J. 2002 Oct;20(4):819-25. doi: 10.1183/09031936.02.00301302.
6
Interpreting thresholds for a clinically significant change in health status in asthma and COPD.解读哮喘和慢性阻塞性肺疾病(COPD)健康状况临床显著变化的阈值
Eur Respir J. 2002 Mar;19(3):398-404. doi: 10.1183/09031936.02.00063702.
7
Underdiagnosis of chronic obstructive pulmonary disease in Northern Sweden.瑞典北部慢性阻塞性肺疾病的诊断不足
Int J Tuberc Lung Dis. 2002 Jan;6(1):76-84.
8
Health status measurement in chronic obstructive pulmonary disease.慢性阻塞性肺疾病的健康状况测量
Thorax. 2001 Nov;56(11):880-7. doi: 10.1136/thorax.56.11.880.
9
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: National Heart, Lung, and Blood Institute and World Health Organization Global Initiative for Chronic Obstructive Lung Disease (GOLD): executive summary.慢性阻塞性肺疾病诊断、管理及预防全球策略:美国国立心肺血液研究所与世界卫生组织慢性阻塞性肺疾病全球倡议组织(GOLD):执行摘要
Respir Care. 2001 Aug;46(8):798-825.
10
Determinants of different dimensions of disease severity in asthma and COPD : pulmonary function and health-related quality of life.哮喘和慢性阻塞性肺疾病中疾病严重程度不同维度的决定因素:肺功能与健康相关生活质量
Chest. 2001 Apr;119(4):1034-42. doi: 10.1378/chest.119.4.1034.